Diaz Mora Prameyllawati on Going Beyond the Price Tag for Gene Therapies in Hemophilia
Diaz Mora Prameyllawati, PhD Candidate at Erasmus MC, shared on LinkedIn:
”Beyond the price tag of gene therapy
Gene therapies are often discussed in terms of their high price, which can range from €1 to €3.5 million per individual.
In our latest study on gene therapy for hemophilia, we went beyond the price tag and focused on what it actually takes to deliver these therapies in clinical practice.
To support successful and sustainable implementation, we developed:
- A detailed process map covering all care activities from site preparation to follow-up.
- Comprehensive cost catalogs capturing every component of care, enabling other hospitals and countries to estimate their own delivery costs.
These tools aim to inform economic evaluations, reimbursement discussions, and the real-world implementation of gene therapy for hemophilia.
More details in our latest publication.
This work was made possible through the support of the SYMPHONY consortium.
I sincerely thank all participating healthcare professionals for their openness and valuable insights during the interviews, as well as my supervisors and co-authors for their guidance and collaboration throughout the study.”
Read the full article here.
Article: Health care resources and costs associated with delivering gene therapy for hemophilia in clinical practice
Authors: Diaz M. Prameyllawati, Caroline M.A. Mussert, Martijn A.H. Oude Voshaar, Hester F. Lingsma, Marjon H. Cnossen, Michiel Coppens, Karina Meijer, Paul R. van der Valk, Frank W.G. Leebeek, Renske M.T. ten Ham
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 12:46Rosa Hart: Inside Pediatric Stroke Recovery with Dr. Catherine Schuster
-
Apr 14, 2026, 12:39Gonzalo Ladreda: Innovation in Stroke Care Is About Timing, Integration, and Real-World Usability
-
Apr 14, 2026, 12:30Roy P.C. Kessels: Stroke’s Cognitive Impact on Young Adults Is Significant and Often Overlooked
-
Apr 14, 2026, 12:22Mehari Gebreyohanns: New Insights on Wake-Up Strokes from Emergency Settings in Texas and Louisiana
-
Apr 14, 2026, 12:08Enrico Ferro: Comparative Study Raises Questions on PFA Safety in AF at EHRA 2026
-
Apr 14, 2026, 11:39Prachi Patel: How B Vitamins and Large-Scale Research Are Shaping Stroke Prevention
-
Apr 14, 2026, 11:28Jamie Brannigan: Help Shape the Future of Brain-Computer Interfaces in Stroke and Neurological Care
-
Apr 14, 2026, 11:18David Ferri: A Fontan Conduit Thrombosis Managed With an Innovative Catheter-Based Thrombectomy
-
Apr 14, 2026, 09:51Understanding Bleeding Disorder of Unknown Cause – EHC